Morgan Stanley’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.01M Buy
739,808
+11,297
+2% +$91.7K ﹤0.01% 3905
2025
Q1
$5.13M Sell
728,511
-16,674
-2% -$117K ﹤0.01% 3905
2024
Q4
$5.54M Sell
745,185
-31,505
-4% -$234K ﹤0.01% 3909
2024
Q3
$3.83M Buy
776,690
+30,456
+4% +$150K ﹤0.01% 4168
2024
Q2
$3.83M Sell
746,234
-45,573
-6% -$234K ﹤0.01% 4105
2024
Q1
$4.2M Sell
791,807
-785,597
-50% -$4.17M ﹤0.01% 4042
2023
Q4
$9.76M Buy
1,577,404
+782,463
+98% +$4.84M ﹤0.01% 3936
2023
Q3
$6M Sell
794,941
-22,553
-3% -$170K ﹤0.01% 3590
2023
Q2
$7.91M Sell
817,494
-51,606
-6% -$499K ﹤0.01% 3395
2023
Q1
$3.28M Buy
869,100
+229,501
+36% +$866K ﹤0.01% 4120
2022
Q4
$4.14M Buy
639,599
+24,562
+4% +$159K ﹤0.01% 3916
2022
Q3
$5.47M Buy
615,037
+6,246
+1% +$55.5K ﹤0.01% 3608
2022
Q2
$6.07M Buy
608,791
+18,911
+3% +$189K ﹤0.01% 3583
2022
Q1
$6.83M Sell
589,880
-11,897
-2% -$138K ﹤0.01% 3340
2021
Q4
$6.68M Buy
601,777
+10,572
+2% +$117K ﹤0.01% 3411
2021
Q3
$5.45M Buy
591,205
+556,091
+1,584% +$5.13M ﹤0.01% 3593
2021
Q2
$394K Buy
35,114
+20,117
+134% +$226K ﹤0.01% 5674
2021
Q1
$159K Sell
14,997
-170,446
-92% -$1.81M ﹤0.01% 5784
2020
Q4
$2.01M Sell
185,443
-49,190
-21% -$533K ﹤0.01% 4156
2020
Q3
$2.28M Sell
234,633
-140,008
-37% -$1.36M ﹤0.01% 3543
2020
Q2
$2.98M Buy
374,641
+320,043
+586% +$2.55M ﹤0.01% 3199
2020
Q1
$474K Sell
54,598
-46,989
-46% -$408K ﹤0.01% 4401
2019
Q4
$1.15M Sell
101,587
-23,123
-19% -$261K ﹤0.01% 4448
2019
Q3
$1.36M Buy
124,710
+72,380
+138% +$787K ﹤0.01% 4099
2019
Q2
$492K Buy
52,330
+44,257
+548% +$416K ﹤0.01% 4614
2019
Q1
$100K Sell
8,073
-89,651
-92% -$1.11M ﹤0.01% 5395
2018
Q4
$1.16M Buy
97,724
+14,217
+17% +$168K ﹤0.01% 4179
2018
Q3
$1.2M Buy
83,507
+12,012
+17% +$173K ﹤0.01% 4393
2018
Q2
$1.07M Sell
71,495
-1,964
-3% -$29.3K ﹤0.01% 4596
2018
Q1
$958K Buy
73,459
+3,463
+5% +$45.2K ﹤0.01% 4572
2017
Q4
$882K Buy
69,996
+18,549
+36% +$234K ﹤0.01% 4624
2017
Q3
$666K Buy
51,447
+20,590
+67% +$267K ﹤0.01% 4698
2017
Q2
$459K Sell
30,857
-6,255
-17% -$93K ﹤0.01% 4857
2017
Q1
$446K Sell
37,112
-42,354
-53% -$509K ﹤0.01% 4910
2016
Q4
$1.1M Buy
79,466
+72,438
+1,031% +$1,000K ﹤0.01% 4393
2016
Q3
$94K Buy
7,028
+6,028
+603% +$80.6K ﹤0.01% 5330
2016
Q2
$10K Sell
1,000
-13,869
-93% -$139K ﹤0.01% 6061
2016
Q1
$156K Buy
14,869
+12,183
+454% +$128K ﹤0.01% 5108
2015
Q4
$32K Sell
2,686
-34,873
-93% -$415K ﹤0.01% 5877
2015
Q3
$439K Buy
37,559
+30,466
+430% +$356K ﹤0.01% 4683
2015
Q2
$103K Sell
7,093
-165,785
-96% -$2.41M ﹤0.01% 5568
2015
Q1
$2.41M Sell
172,878
-118,597
-41% -$1.65M ﹤0.01% 3424
2014
Q4
$4.03M Sell
291,475
-1,423
-0.5% -$19.7K ﹤0.01% 2931
2014
Q3
$3.59M Buy
292,898
+4,873
+2% +$59.7K ﹤0.01% 2931
2014
Q2
$3.6M Buy
288,025
+9,340
+3% +$117K ﹤0.01% 2981
2014
Q1
$3.11M Buy
278,685
+14,185
+5% +$158K ﹤0.01% 3039
2013
Q4
$3.21M Buy
264,500
+217,719
+465% +$2.64M ﹤0.01% 2987
2013
Q3
$571K Sell
46,781
-34,300
-42% -$419K ﹤0.01% 4240
2013
Q2
$1.07M Buy
+81,081
New +$1.07M ﹤0.01% 3678